Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

16.29

-0.19 (-1.15%)

At close: Aug 28, 2026, 4:00 PM EDT

16.35

+0.06 (0.37%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Aurinia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	179.73	80.16	83.4	48.76	94.09	231.64
Short-Term Investments	263.29	317.78	275.04	301.61	295.22	234.18
Cash & Short-Term Investments	443.02	397.94	358.44	350.37	389.31	465.82
Cash Growth	40.62%	11.02%	2.30%	-10.00%	-16.43%	16.94%
Accounts Receivable	41.14	41.45	36.54	24.09	13.48	15.41
Other Receivables	1	0.7	0.6	0.7	1.1	-
Receivables	42.14	42.15	37.14	24.79	14.58	15.41
Inventory	45.15	45.69	39.23	39.71	24.75	19.33
Prepaid Expenses	10.53	5.75	11.22	9.49	13.58	11.71
Restricted Cash	0.1	0.05	0.04	0.12	0.08	0.26
Other Current Assets	0.38	0.38	0.53	0.33	0.23	0.8
Total Current Assets	541.32	491.97	446.6	424.8	442.54	513.32
Property, Plant & Equipment	68.53	79.57	98.87	116.57	8.56	9.8
Long-Term Investments	-	-	-	0.2	-	-
Other Intangible Assets	3.38	3.76	4.36	4.98	6.43	8.4
Long-Term Deferred Tax Assets	178.94	176.19	-	-	-	-
Other Long-Term Assets	0.09	0.09	0.82	1.52	13.34	11.84
Total Assets	792.26	751.59	550.65	548.06	470.86	543.37

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.74	3.31	5.19	4.33	3.09	3.88
Accrued Expenses	64.11	66.47	54.12	50.06	36.28	30.25
Current Portion of Leases	18.18	17.59	15.07	15.6	0.94	1.06
Current Income Taxes Payable	-	-	-	-	0.63	0.81
Current Unearned Revenue	10.59	3.72	11	4.81	3.15	0.19
Other Current Liabilities	5.27	2.63	12.39	2.39	2.03	4.45
Total Current Liabilities	99.89	93.72	97.76	77.19	46.11	40.65
Long-Term Leases	45.95	57.22	64.3	82.01	7.15	7.68
Long-Term Unearned Revenue	7.48	12.65	1.7	-	-	-
Other Long-Term Liabilities	0.95	6.66	9.41	10.91	12.17	15.95
Total Liabilities	177.4	170.26	173.17	170.11	65.43	64.28

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1,117	1,120	1,188	1,200	1,185	1,177
Additional Paid-In Capital	76.19	111.26	127	120.79	85.49	59.01
Retained Earnings	-577.6	-649.37	-936.57	-942.32	-864.3	-756.12
Comprehensive Income & Other	-0.98	-0.6	-0.65	-0.73	-1.06	-0.85
Shareholders' Equity	614.86	581.33	377.48	377.95	405.44	479.09
Total Liabilities & Equity	792.26	751.59	550.65	548.06	470.86	543.37

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	64.14	74.81	79.37	97.61	8.09	8.74
Net Cash (Debt)	378.89	323.13	279.07	252.76	381.22	457.08
Net Cash Growth	62.46%	15.79%	10.41%	-33.70%	-16.60%	17.22%
Net Cash Per Share	2.78	2.33	1.91	1.76	2.69	3.53
Filing Date Shares Outstanding	133.05	132.97	137.34	144.62	142.58	141.65
Total Common Shares Outstanding	132.91	132.32	140.88	143.83	142.27	141.6
Working Capital	441.43	398.24	348.83	347.61	396.43	472.68
Book Value Per Share	4.63	4.39	2.68	2.63	2.85	3.38
Tangible Book Value	611.49	577.57	373.12	372.98	399.01	470.69
Tangible Book Value Per Share	4.60	4.36	2.65	2.59	2.80	3.32
Machinery	2.02	2.02	2.02	2.02	1.87	1.88
Construction In Progress	-	-	-	-	0.26	0.39
Leasehold Improvements	3.24	3.24	3.24	3.24	2.98	2.98

SEC Filings: 10-K · 10-Q